Zobrazeno 1 - 10
of 20
pro vyhledávání: '"O. K. Batsunov"'
Autor:
N. A. Arsentieva, O. K. Batsunov, N. E. Lyubimova, V. V. Basina, E. V. Esaulenko, Areg A. Totolian
Publikováno v:
Медицинская иммунология, Vol 26, Iss 6, Pp 1235-1248 (2024)
Chronic hepatitis C (CHC) represents a significant public health concern. In the majority of cases, the infection progresses to a chronic form, which is characterised by the development of fibrosis and cirrhosis of the liver. A plethora of cytokines
Externí odkaz:
https://doaj.org/article/2b420ed62a4946fc8e3cab748ba97e4a
Autor:
Natalia A. Arsentieva, O. K. Batsunov, N. E. Liubimova, V. V. Basina, E. V. Esaulenko, A. A. Totolian
Publikováno v:
Инфекция и иммунитет, Vol 14, Iss 3, Pp 609-614 (2024)
Hepatitis B is an infectious disease resulting from infection with the hepatitis B virus. Chronic hepatitis B (CHB) is characterized by prolonged inflammation in the liver, the development of fibrosis, liver cirrhosis and hepatocellular carcinoma. Fa
Externí odkaz:
https://doaj.org/article/04e26e675b1f42ccba4e6d58c8bcf6bb
Autor:
N. A. Arsentieva, N. E. Liubimova, O. K. Batsunov, Z. R. Korobova, R. N. Kuznetsova, A. A. Rubinstein, O. V. Stanevich, A. A. Lebedeva, E. A. Vorobyov, S. V. Vorobyova, A. N. Kulikov, E. G. Gavrilova, D. E. Pevtcov, Yu. S. Polushin, I. V. Shlyk, A. A. Totolian
Publikováno v:
Инфекция и иммунитет, Vol 12, Iss 5, Pp 859-868 (2022)
In our study, we aimed to evaluate the significance of specific cytokines in blood plasma as predictive markers of COVID-associated mortality. Materials and methods. In plasma samples of 29 patients with PCR-confirmed COVID-19 we measured the concent
Externí odkaz:
https://doaj.org/article/0e32790e83f3427898b214b8d04da2f6
Autor:
N. A. Arsentieva, N. E. Liubimova, O. K. Batsunov, Z. R. Korobova, O. V. Stanevich, A. A. Lebedeva, E. A. Vorobyov, S. V. Vorobyova, A. N. Kulikov, D. A. Lioznov, M. A. Sharapova, D. E. Pevtcov, A. A. Totolian
Publikováno v:
Медицинская иммунология, Vol 23, Iss 2, Pp 311-326 (2021)
COVID-19, an infection caused by the new coronavirus SARS-CoV-2, is associated with a number of pathophysiological mechanisms, mobilizing a wide spectrum of biomolecules, mainly, cytokines.The purpose of this study was to evaluate levels of multiple
Externí odkaz:
https://doaj.org/article/6a6c76bfb41641759c37fe25cb4e8e1a
Autor:
A. Yu. Popova, E. B. Ezhlova, A. A. Mel’nikova, N. S. Bashketova, R. K. Fridman, L. V. Lyalina, V. S. Smirnov, I. G. Chkhindzheriya, T. A. Grechaninova, K. A. Agapov, N. A. Arsent’eva, N. A. Bazhenova, O. K. Batsunov, E. M. Danilova, E. V. Zueva, D. V. Komkova, R. N. Kuznetsova, N. E. Lyubimova, A. N. Markova, I. V. Khamitova, V. I. Lomonosova, V. V. Vetrov, A. M. Milichkina, V. G. Dedkov, A. A. Totolyan
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 3, Pp 124-130 (2020)
The first case of COVID-19 was diagnosed in St. Petersburg on March 2, 2020; the period of increase in the incidence lasted for 10 weeks, the maximum rates were recorded in mid-May, and subsequently there was a statistically significant decrease in t
Externí odkaz:
https://doaj.org/article/4e0844a02f4b4e1dbe365d3d630b161d
Autor:
A. Yu. Popova, E. B. Ezhlova, A. A. Mel’nikova, O. A. Historik, O. S. Mosevich, L. V. Lyalina, V. S. Smirnov, M. A. Cherny, N. S. Balabysheva, I. S. Loginova, O. S. Vladimirova, I. S. Samoglyadova, N. A. Vasev, S. V. Rumyantseva, E. Yu. Chupalova, G. V. Selivanova, M. V. Muraviova, L. V. Timofeeva, E. N. Khankishieva, V. D. Tylchevskaya, N. D. Nikitenko, T. I. Kostenitskaya, N. V. Virkunen, I. M. Klimkina, T. M. Kuzmina, N. V. Degtyarenko, A. I. Bazunova, L. A. Filippova, N. A. Palchikova, A. V. Kukshkin, N. A. Arsentieva, O. K. Batsunov, E. A. Bogumilchik, E. A. Voskresenskaya, V. G. Drobyshevskaya, E. V. Zueva, G. I. Kokorina, N. N. Kurova, N. E. Lyubimova, R. S. Ferman, G. N. Khamdulaeva, I. V. Khamitova, E. V. Khorkova, A. M. Milichkina, V. G. Dedkov, A. A. Totolian
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 3, Pp 114-123 (2020)
The first case of COVID-19 was registered in the Leningrad Region on March 13, 2020. The period of increasing intensity of the epidemic process lasted 8 weeks. One month after reaching the maximum incidence rate, a study was organized to determine se
Externí odkaz:
https://doaj.org/article/ab288c244b274876987cbf186918cad2
Publikováno v:
Медицинская иммунология, Vol 22, Iss 4, Pp 765-778 (2020)
The cytokine system is a large group of humoral factors produced by immune cells and involved in the pathogenesis of most human diseases. To assess the significance of changes in cytokines/chemokines under pathological conditions, appropriate referen
Externí odkaz:
https://doaj.org/article/72a918e3d3ec4edb9f2fc91c0219a894
Publikováno v:
Медицинская иммунология, Vol 22, Iss 3, Pp 433-442 (2020)
Low-affinity Fcγ-receptors that recognize the Fc portion of immunoglobulin (Ig) molecules, usually being in antigen-bound state, thus representing a link between innate and adaptive immunity. They play a significant role in inflammatory and infectio
Externí odkaz:
https://doaj.org/article/83575117fadb4751bec5261a64ca79f2
Autor:
O. K. Batsunov, N. A. Arsentieva, N. E. Lyubimova, E. V. Esaulenko, A. V. Semenov, Areg A. Totolyan
Publikováno v:
Медицинская иммунология, Vol 22, Iss 2, Pp 291-300 (2020)
Hepatitis B is an infectious viral disease in which damage or destruction of liver tissue occurs, and which can turn into a chronic form. In chronic hepatitis B (CHB), hepatocytes are replaced by connective tissue as they die, resulting in fibrosis,
Externí odkaz:
https://doaj.org/article/d43b7330c5304e90895bc01ebc881c6e
Autor:
V. V. Basina, N. A. Arsentieva, O. K. Batsunov, N. E. Lyubimova, A. V. Semenov, E. V. Esaulenko, Areg A. Totolian
Publikováno v:
Медицинская иммунология, Vol 21, Iss 1, Pp 107-120 (2019)
The work presents data on forty-one patients with chronic hepatitis C (HCV, genotype 1), at different liver fibrosis stages. The studies were performed in the course of interferon-containing treatment regimens, i.e., pegylated interferon combined wit
Externí odkaz:
https://doaj.org/article/df56545f05d042e9b358ccfe26c4cc04